ETR:SBS Stratec (SBS) Stock Price, News & Analysis €26.75 -1.05 (-3.78%) As of 08/1/2025 Add Compare Share Share Stock Analysis Stock AnalysisChartHeadlinesBuy This Stock About Stratec Stock (ETR:SBS) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Stratec alerts:Sign Up Key Stats Today's Range€26.55▼€27.9050-Day Range€23.45▼€29.4052-Week Range€36.00▼€49.65Volume11,558 shsAverage Volume6,253 shsMarket Capitalization€321.37 millionP/E Ratio32.10Dividend Yield2.06%Price TargetN/AConsensus RatingN/A Company Overview Stratec SE, together with its subsidiaries, designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany, European Union, and internationally. It designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers; and offers complex consumables for diagnostics and medical applications. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018. Stratec SE was founded in 1979 and is headquartered in Birkenfeld, Germany. Read More Receive SBS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Stratec and its competitors with MarketBeat's FREE daily newsletter. Email Address SBS Stock News HeadlinesOwning 42% shares,institutional owners seem interested in Stratec SE (ETR:SBS),July 30, 2025 | finance.yahoo.comStratec SE's (ETR:SBS) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock?July 8, 2025 | finance.yahoo.comLeaked Gov’t Memo Reveals $100 Trillion DeadlineOnly Days Left to Claim Your Share of Trump's $100T Play Trump's economic blueprint is about to go live, and the deadline is fast-approaching. A new federal plan could legally unlock $100 trillion in U.S. resources... and one $10 stock could lead the charge. Former hedge fund manager Whitney Tilson explains how to act now, before this hits the headlines. | Stansberry Research (Ad)Stratec (ETR:SBS) shareholders have endured a 73% loss from investing in the stock three years agoJune 22, 2025 | finance.yahoo.comStratec Full Year 2024 Earnings: EPS Beats ExpectationsMay 21, 2025 | finance.yahoo.comStratec SE (SBS.BE)April 13, 2025 | uk.finance.yahoo.comStratec (ETR:SBS) Hasn't Managed To Accelerate Its ReturnsMarch 25, 2025 | finance.yahoo.comEQS-News: STRATEC ANNOUNCES CHANGES TO 2025 FINANCIAL CALENDARMarch 19, 2025 | markets.businessinsider.comSee More Headlines SBS Stock Analysis - Frequently Asked Questions How have SBS shares performed this year? Stratec's stock was trading at €29.80 at the start of the year. Since then, SBS stock has decreased by 10.2% and is now trading at €26.75. What other stocks do shareholders of Stratec own? Based on aggregate information from My MarketBeat watchlists, some other companies that Stratec investors own include Great Portland Estates (GPOR), Gogo (GOGO), Depomed (DEPO), Cenovus Energy (CVE), China Hydroelectric Corp Foreign (CHC), Bio-Rad Laboratories (BIO) and Berkshire Hills Bancorp (BHLB). Industry, Sector and Symbol Stock ExchangeETR SectorMedical Industry Medical Devices Sub-IndustryUtilities Current SymbolETR:SBS CIKN/A Webwww.stratec.com Phone+49-7082-79160FaxN/AEmployees1,464Year FoundedN/AProfitability EPS (Trailing Twelve Months)€0.83 Trailing P/E Ratio32.10 Forward P/E Ratio7.43 P/E Growth10.43Net Income€9.89 million Net Margins4.00% Pretax MarginN/A Return on Equity4.36% Return on Assets4.09% Debt Debt-to-Equity Ratio66.97 Current Ratio2.52 Quick Ratio1.65 Sales & Book Value Annual Sales€247.60 million Price / Sales1.30 Cash Flow€1.12 per share Price / Cash Flow23.85 Book Value€18.74 per share Price / Book1.43Miscellaneous Outstanding Shares12,013,727Free FloatN/AMarket Cap€321.37 million OptionableNot Optionable Beta0.16 These 7 Stocks Will Be Magnificent in 2025Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free Report This page (ETR:SBS) was last updated on 8/3/2025 by MarketBeat.com Staff From Our PartnersMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredEx-Hedge Fund Manager Uncovers $100 Trillion Land ShiftTrump's Radical New Plan Could Enrich Thousands This isn't a campaign stunt. It's a $100 trillion move to u...Stansberry Research | SponsoredInvestigating the Most Controversial Stock on EarthTesla’s wild price swings may not be random after all. Hedge fund veteran Larry Benedict has uncovered a st...Brownstone Research | SponsoredThis New Rule Could Change EverythingA major change is quietly going into effect this July — and Wall Street is already positioning for it. Big ...American Alternative | SponsoredSell these "safe" blue chips immediatelyInvesting Legend Hints the End May be Near for These 3 Iconic Stocks One company to replace Amazon… another...InvestorPlace | SponsoredToo busy to trade? Good.Too busy to trade? That might be your edge. This after-hours strategy is built for people who don’t sit at ...Timothy Sykes | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Stratec SE Please log in to your account or sign up in order to add this asset to your watchlist. Share Stratec With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SBS Stock Alerts